Pharma-Bio Serv, Inc.
PBSV
$0.50
$0.012.04%
OTC PK
| 01/31/2026 | 10/31/2025 | ||||
|---|---|---|---|---|---|
| Revenue | 6.76% | 9.50% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | 6.76% | 9.50% | |||
| Cost of Revenue | 12.27% | 0.86% | |||
| Gross Profit | -3.54% | 30.40% | |||
| SG&A Expenses | -7.40% | -0.66% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 4.67% | 0.26% | |||
| Operating Income | 29.11% | 57.53% | |||
| Income Before Tax | 748.84% | 102.06% | |||
| Income Tax Expenses | -18.18% | 191.67% | |||
| Earnings from Continuing Operations | 33,000.00% | 99.95% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 33,000.00% | 99.95% | |||
| EBIT | 29.11% | 57.53% | |||
| EBITDA | 32.17% | 60.58% | |||
| EPS Basic | -- | 100.00% | |||
| Normalized Basic EPS | 900.00% | 101.75% | |||
| EPS Diluted | -- | 100.00% | |||
| Normalized Diluted EPS | 900.00% | 101.75% | |||
| Average Basic Shares Outstanding | -0.17% | 0.08% | |||
| Average Diluted Shares Outstanding | -0.14% | 0.03% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||